Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  27 نتائج ل ""Phosphofructokinase-2""

فلترة النتائج

Publisher : biomed central
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.

  • Authors : Egelberg M; Division of Surgery, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, BMC D13, Lund, 221 83, Sweden. .; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden. .

Subjects: Phosphofructokinase-2*/Phosphofructokinase-2*/Phosphofructokinase-2*/genetics ; Phosphofructokinase-2*/Phosphofructokinase-2*/Phosphofructokinase-2*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/radiotherapy

  • Source: BMC cancer [BMC Cancer] 2025 Feb 28; Vol. 25 (1), pp. 374. Date of Electronic Publication: 2025 Feb 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair.

  • Authors : Xiao Y; Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.; National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital), Beijing, 100191, China.

Subjects: Phosphofructokinase-2*/Phosphofructokinase-2*/Phosphofructokinase-2*/genetics ; Phosphofructokinase-2*/Phosphofructokinase-2*/Phosphofructokinase-2*/metabolism ; Phosphofructokinase-2*/Phosphofructokinase-2*/Phosphofructokinase-2*/antagonists & inhibitors

  • Source: Cell communication and signaling : CCS [Cell Commun Signal] 2025 Jan 25; Vol. 23 (1), pp. 48. Date of Electronic Publication: 2025 Jan 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Micheliolide attenuates sepsis-induced acute lung injury by suppressing mitochondrial oxidative stress and PFKFB3-driven glycolysis.

  • Authors : Li W; Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, 510515, China.; Li Y

Subjects: Glycolysis*/Glycolysis*/Glycolysis*/drug effects ; Sepsis*/Sepsis*/Sepsis*/complications ; Sepsis*/Sepsis*/Sepsis*/drug therapy

  • Source: Journal of translational medicine [J Transl Med] 2025 Feb 14; Vol. 23 (1), pp. 181. Date of Electronic Publication: 2025 Feb 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis.

  • Authors : Zhang Y; Department of Urology, the First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, People's Republic of China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, People's Republic of China.

Subjects: Receptors, CXCR4*/Receptors, CXCR4*/Receptors, CXCR4*/metabolism ; Receptors, CXCR4*/Receptors, CXCR4*/Receptors, CXCR4*/genetics ; Glycolysis*

  • Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Sep 26; Vol. 22 (1), pp. 456. Date of Electronic Publication: 2024 Sep 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.

  • Authors : Feng C; Department of Urology, Huashan Hospital, Fudan University, 12 Middle Urumqi Rd, 200040, Shanghai, PR China.; Institute of Urology, Fudan University, 200040, Shanghai, PR China.

Subjects: Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*pathology ; Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/*drug effects ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*secondary

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Sep 30; Vol. 40 (1), pp. 308. Date of Electronic Publication: 2021 Sep 30.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.

  • Authors : Liu XT; Centenary Institute of Cancer Medicine and Cell Biology, The University of Sydney, Sydney, NSW, 2050, Australia.; Huang Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics ; Phosphotransferases (Alcohol Group Acceptor)*

  • Source: Journal of translational medicine [J Transl Med] 2024 Jan 10; Vol. 22 (1), pp. 43. Date of Electronic Publication: 2024 Jan 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth.

  • Authors : Yun HJ; Department of Health Sciences, The Graduate School of Dong-A University, Busan, 49315, Republic of Korea.; Li M

Subjects: AMP-Activated Protein Kinases* ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology; Humans

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Dec 15; Vol. 42 (1), pp. 340. Date of Electronic Publication: 2023 Dec 15.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Integrated epigenome, whole genome sequence and metabolome analyses identify novel multi-omics pathways in type 2 diabetes: a Middle Eastern study.

  • Authors : Yousri NA; Genetic Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar. .; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/genetics ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Epigenome*

  • Source: BMC medicine [BMC Med] 2023 Sep 08; Vol. 21 (1), pp. 347. Date of Electronic Publication: 2023 Sep 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Hyperglycemia induces PFKFB3 overexpression and promotes malignant phenotype of breast cancer through RAS/MAPK activation.

  • Authors : Cheng X; Department of Histopathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, 315000, Zhejiang, China.; Jia X

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/complications ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/genetics

  • Source: World journal of surgical oncology [World J Surg Oncol] 2023 Mar 28; Vol. 21 (1), pp. 112. Date of Electronic Publication: 2023 Mar 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.

  • Authors : Yang K; Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, #37 Guo-Xue-Xiang, Chengdu, 610041, Sichuan, China.; Department of Pediatric Surgery, Guangzhou Women and Children's Medical Centre, National Children's Medical Centre for South Central Region, Guangzhou Medical University, Guangzhou, 510623, China.

Subjects: Phosphatidylinositol 3-Kinases*/Phosphatidylinositol 3-Kinases*/Phosphatidylinositol 3-Kinases*/metabolism ; Hemangioma*/Hemangioma*/Hemangioma*/metabolism; Infant

  • Source: Journal of translational medicine [J Transl Med] 2023 Feb 06; Vol. 21 (1), pp. 85. Date of Electronic Publication: 2023 Feb 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  27 نتائج ل ""Phosphofructokinase-2""